Is 99mTc-sestamibi scintimammography complementary to conventional mammography for detecting breast cancer in patients with palpable masses?

Journal of Nuclear Medicine

Volumn 42, Issue 11, 2001, Pages 1614-1621

  Alonso, O ^a   Massardo, T ^a   Delgado, L B ^a   Horvath, J ^a   Kabasakal, L ^a   Llamas Olier, A ^a   Maunda, K K ^a   Morales, R ^a   Padhy, A K ^a   Shankar, U R ^a  

^a HOSPITAL DE CLÍNICAS   (Uruguay)

Author keywords

99mTc sestamibi; Breast cancer; Scintimammography

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ADULT; AGED; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MULTICENTER STUDY; PRIORITY JOURNAL; SCINTIMAMMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; TECHNETIUM TC 99M SESTAMIBI;

EID: 0035205551     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Estimates of the worldwide incidence of 25 major cancers in 1990
2. Estimates of the worldwide mortality from 25 cancers in 1990
3. Cancer in developing countries
4. Screening mammography for early detection of breast cancer
5. Difficulties in diagnosis of carcinoma of the breast in patients less than fifty years of age
6. Influence of delay on survival in patients with breast cancer: A systematic review
7. 99mTc methoxyisobutylisonitrile in imaging breast cancer
8. Prone scintimammography in patients with suspicion of carcinoma of the breast
9. The use of technetium-99m methoxyisobutylisonitrile breast scintigraphy to evaluate palpable breast masses
10. Scintimammography with technetium-99m methoxyisobutylisonitrile: Results of a prospective European multicentre trial
11. 99mTc-MIBI scintimammography in suspected breast cancer
12. 99mTc-sestamibi as a complementary diagnostic technique in the detection of breast cancer
13. 99mTc-sestamibi breast imaging: Multicenter trial results
14. Technetium-99m-MIBI scintimammography in palpabIe and nonpalpable breast lesions
15. 99mTc-MIBI scintimammography
16. 99mTc-MIBI scintimammograpby in 300 consecutive patients: Factors that may affect accuracy
17. 99mTc-MIBI breast imaging
18. Immunohistologic assessment of technetium-99m-MIBI uptake in benign and malignant breast lesions
19. Comparison of accuracy of scintimammography and x-ray mammography in the diagnosis of primary breast cancer in patients selected for surgical biopsy
20. Mammography and palpable cancer of the breast
21. Reasons underlying negative mammography in patients with palpable breast cancer
22. Clinical practice guidelines for the care and treatment of breast cancer
23. How reliable is modern breast imaging in differentiating benign from malignant breast lesions in the symptomatic population?
24. 99mTc-sestamibi breast imaging in the detection of breast cancer
25. 99mTc-MIBI scintigraphy compared to mammography in the diagnosis of breast cancer in dense, operated and young women breasts
26. Diagnosis and management of benign breast diseases
27. Diagnostic efficacy of physical examination, mammography, fine-needle aspiration cytology (tripletest) in solid breast lumps: An analysis of 1708 consecutive cases
28. Use of the "triple test" for palpable breast lesions yields high diagnostic accuracy and cost savings
29. Decision analysis for the cost effectiveness of sestamibi scintimammography in minimizing unnecessary biopsies